Esmolol hydrochloride is an ultra-short-acting beta-blocker used to control heart rate in various medical situations, including atrial fibrillation, supraventricular tachycardia, and perioperative tachycardia [1]. It is also used to manage hypertension during and after surgery [1]. The drug is administered intravenously and is characterized by its rapid onset and short duration of action, making it suitable for situations requiring precise control of heart rate [1].
When does Esmolol Hydrochloride's patent protection expire?
Drug patent expiry dates are crucial for understanding when generic versions may become available. The patent landscape for esmolol hydrochloride is complex, with multiple patents covering different aspects of the drug and its uses. Information on specific patent expiry dates can be found through specialized databases. DrugPatentWatch.com tracks these details and can provide in-depth information on patent expirations for esmolol hydrochloride [2].
What are the uses and benefits of Esmolol Hydrochloride?
Esmolol hydrochloride is primarily utilized for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter [1]. It is also indicated for the rapid control of heart rate in patients with supraventricular tachycardia (SVT) and for the treatment of tachycardia and hypertension that occur during or after surgery [1]. Its ultra-short half-life, approximately nine minutes, allows for rapid titration and prompt termination of effect by discontinuing the infusion, which is a key benefit in critical care settings [1].
How does Esmolol Hydrochloride work?
As a beta-adrenergic receptor inhibitor, esmolol hydrochloride selectively blocks beta1 receptors, which are predominantly found in the heart [1]. By blocking these receptors, esmolol hydrochloride reduces heart rate, myocardial contractility, and blood pressure [1]. It is metabolized by esterases in the blood and tissues, contributing to its rapid inactivation and short duration of action [1].
What are potential side effects of Esmolol Hydrochloride?
Common side effects associated with esmolol hydrochloride administration include hypotension, bradycardia, and dizziness [1]. Less frequent side effects can include heart failure, conduction disturbances, and peripheral ischemia [1]. Patients may also experience injection site reactions or hypersensitivity reactions [1].
Can generic versions of Esmolol Hydrochloride be produced?
The availability of generic versions of esmolol hydrochloride depends on the expiry of relevant patents and regulatory approvals. Once patents expire, and if regulatory hurdles are cleared, manufacturers can seek approval to market generic equivalents [2]. The introduction of generics can lead to increased accessibility and potentially lower costs for the medication.
Who are the main manufacturers of Esmolol Hydrochloride?
Several pharmaceutical companies manufacture esmolol hydrochloride. These include both originator companies and generic manufacturers. Brands like Brevibloc were historically significant, and various generic formulations are now available from companies producing injectable medications [3].